Johnathan Ebben

Johnathan Ebben, MD, Ph.D., is a highly experienced professional in the field of translational medicine, currently serving as a Principal Scientist and Clinical Director at Merck. In addition to this role, Johnathan serves as the Tumor Board Tuesday Project Manager and has co-founded NanoRED Biotechnology. Johnathan also holds the position of Entrepreneurial Lead with the National Science Foundation Innovation Corps, showcasing a commitment to innovation and entrepreneurship in the biomedical sector.